Form 4: Hartford CEO Swift Exercises Options, Sells Shares
Insider Trading Report
Christopher Swift, Chairman and CEO of Hartford Insurance Group, exercised stock options and subsequently sold a portion of the acquired shares as part of a pre-arranged trading plan.
Summary
- Christopher Swift, Chairman and CEO of Hartford Insurance Group, exercised 100,970 stock options on February 4, 2026, at an exercise price of $48.89 per share.
- These options were granted in 2017 and were scheduled to expire on February 28, 2027, having become fully exercisable on February 28, 2020.
- Following the exercise, Swift sold a total of 100,970 shares of common stock, consisting of 19,778 shares at a weighted average price of $141.1913 (ranging from $141 to $141.47) and 81,192 shares at a weighted average price of $140.6763 (ranging from $140 to $140.99).
- The transactions were conducted under a Rule 10b5-1 trading plan adopted on November 3, 2025.
- After these transactions, Swift directly beneficially owns 194,816.948 shares of common stock and indirectly owns 40,003 shares via his spouse, 95,386 shares via Swift Family Gift Trust, and 60,865 shares via Swift Family Legacy Trust.
- Swift retains significant derivative holdings, including 2,042,263 stock options with various exercise prices ranging from $49.01 to $116.41 and expiration dates extending to February 25, 2035.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a routine, pre-planned executive compensation event. The significant profit realized by the CEO from long-held options is a positive for executive incentives, and the continued substantial equity holdings demonstrate ongoing alignment with shareholder interests.
Positives
- The CEO realized a significant profit from exercising options granted at a much lower price ($48.89) and selling shares at a substantially higher market price (around $140-$141).
- The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and transparent approach to insider trading, which reduces concerns about opportunistic selling.
- Swift retains a substantial direct and indirect beneficial ownership in the company, demonstrating continued alignment with shareholder interests.
Negatives
- The sale of a significant number of shares by the Chairman and CEO could be interpreted by some investors as a reduction in direct exposure to the company's future stock price appreciation, although it was part of a pre-planned strategy.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction, as it pertains solely to an insider's equity transactions.
Management Comments
- The transaction was effected pursuant to a trading plan previously adopted by Mr. Swift on November 3, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
Industry Context
StockSavvy.ai notes that executive stock option exercises and subsequent sales are common occurrences in publicly traded companies, particularly when options are deep in the money. The use of a Rule 10b5-1 trading plan, as seen here, is a standard practice among executives to manage personal finances while adhering to insider trading regulations, providing transparency and mitigating concerns about opportunistic timing.
Comparison to Industry Standards
- StockSavvy.ai observes that the use of Rule 10b5-1 plans for executive stock transactions is a widely adopted best practice across industries, including the insurance sector.
- This practice aligns with corporate governance recommendations from bodies like the Council of Institutional Investors (CII) and is common among peers in the financial services industry, such as executives at Travelers Companies (TRV) or Chubb Limited (CB), who also utilize such plans to manage their equity compensation.
Related Party Transactions
- The transactions represent an insider trading activity by Christopher Swift, the Chairman and CEO, involving the exercise of stock options and subsequent sale of common stock.
- Indirect beneficial ownership is reported through Mr. Swift's spouse and two family trusts (Swift Family Gift Trust and Swift Family Legacy Trust).
Stakeholder Impact
- **Shareholders**: The transaction demonstrates the CEO's ability to monetize long-term equity compensation, which can be viewed positively as a reward for performance. The pre-planned nature of the sale reduces concerns about opportunistic selling. However, a large insider sale could be perceived negatively by some, potentially signaling a lack of confidence, though this is mitigated by the 10b5-1 plan and retained holdings.
- **Employees**: No direct impact on employees is indicated by this filing.
- **Customers**: No direct impact on customers is indicated by this filing.
- **Suppliers**: No direct impact on suppliers is indicated by this filing.
- **Creditors**: No direct impact on creditors is indicated by this filing.
Next Steps
- The remaining unexercised stock options held by Mr. Swift will continue to vest according to their respective schedules, with future exercisable dates extending to February 25, 2028.
- The remaining stock options will expire on various dates, with the latest expiration date being February 25, 2035.
Key Dates
| Date | Description |
|---|---|
| 2017 | Year stock options exercised on Feb 4, 2026 were granted. |
| 2020-02-28 | Date options with $48.89 exercise price became fully exercisable. |
| 2021-02-27 | Date options with $53.81 exercise price became fully exercisable. |
| 2022-02-26 | Date options with $49.01 exercise price became fully exercisable. |
| 2023-02-25 | Date options with $55.27 exercise price became fully exercisable. |
| 2024-02-23 | Date options with $51.87 exercise price became fully exercisable. |
| 2024-02-28 | Date one-third of options with $78.28 exercise price became exercisable. |
| 2025-02-23 | Date options with $69.41 exercise price became fully exercisable. |
| 2025-02-27 | Date one-third of options with $95.74 exercise price became exercisable. |
| 2025-02-28 | Date an additional one-third of options with $78.28 exercise price became exercisable. |
| 2025-11-03 | Date Mr. Swift adopted the Rule 10b5-1 trading plan. |
| 2026-02-04 | Date of option exercise and subsequent stock sales. |
| 2026-02-06 | Date the Form 4 was signed. |
| 2026-02-25 | Date one-third of options with $116.41 exercise price will become exercisable. |
| 2026-02-27 | Date an additional one-third of options with $95.74 exercise price will become exercisable. |
| 2026-02-28 | Date the remaining one-third of options with $78.28 exercise price will become exercisable. |
| 2027-02-25 | Date an additional one-third of options with $116.41 exercise price will become exercisable. |
| 2027-02-27 | Date the remaining one-third of options with $95.74 exercise price will become exercisable. |
| 2027-02-28 | Expiration date of the exercised options (granted in 2017). |
| 2028-02-25 | Date the remaining one-third of options with $116.41 exercise price will become exercisable. |
| 2028-02-27 | Expiration date of options with $53.81 exercise price. |
| 2029-02-26 | Expiration date of options with $49.01 exercise price. |
| 2030-02-25 | Expiration date of options with $55.27 exercise price. |
| 2031-02-23 | Expiration date of options with $51.87 exercise price. |
| 2032-02-23 | Expiration date of options with $69.41 exercise price. |
| 2033-02-28 | Expiration date of options with $78.28 exercise price. |
| 2034-02-27 | Expiration date of options with $95.74 exercise price. |
| 2035-02-25 | Expiration date of options with $116.41 exercise price. |
Recommendation
holdThis Form 4 filing details a routine, pre-scheduled transaction by the CEO to exercise long-held stock options and sell a portion of the resulting shares. While it represents a monetization event for the executive, it was conducted under a Rule 10b5-1 plan, which signals a lack of opportunistic timing. The CEO retains substantial direct and indirect equity holdings, maintaining alignment with shareholder interests. Therefore, this specific filing does not present new information that would warrant a change in investment thesis, suggesting a 'hold' recommendation for existing investors.
Keywords
Hartford Insurance Group, HIG, Christopher Swift, Insider Trading, Form 4, Stock Options, Share Sale, CEO, 10b5-1 Plan, Executive Compensation, Equity Transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.